Brief: Liquidia Says New Litigation Filed Against Co In U.S.

United Therapeutics

12/05/2025 12:09

May 12 (Reuters) - Liquidia Corp LQDA.O:

LIQUIDIA: NEW LITIGATION FILED AGAINST CO IN U.S. ALLEGES INFRINGEMENT OF UNITED THERAPEUTICS '782 PATENT

LIQUIDIA: LITIGATION SEEKS TO ENJOIN LIQUIDIA FROM COMMERCIALIZING YUTREPIA  IF APPROVED BY U.S. FDA

LIQUIDIA CORP: NEW LITIGATION DOES NOT IMPACT FDA'S ABILITY TO TAKE FINAL ACTION ON NDA FOR YUTREPIA ON PDUFA GOAL DATE OF MAY 24

LIQUIDIA CORP: UTHR CURRENTLY NOT SEEKING ANY INJUNCTION AGAINST FDA TO PREVENT FINAL APPROVAL OF NDA FOR YUTREPIA

Source text: ID:nGNX6hMjJf

Further company coverage: LQDA.O

 ((Reuters.Briefs@thomsonreuters.com;))